Johns Hopkins Psychiatry Guide
Lurasidone
INDICATIONS
FDA
FDA
- Schizophrenia in adults and adolescents (age 13-17)
- Bipolar I depression monotherapy in adults and pediatric patients (age 10-17)
- Bipolar I depression adjunct therapy to lithium or valproate in adult patients
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 23, 2025
Citation
Qureshi, Imran. "Lurasidone." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787520/0.0/Lurasidone.
Qureshi I. Lurasidone. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787520/0.0/Lurasidone. Accessed October 8, 2025.
Qureshi, I. (2025). Lurasidone. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787520/0.0/Lurasidone
Qureshi I. Lurasidone [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787520/0.0/Lurasidone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lurasidone
ID - 787520
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/08/23/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787520/0.0/Lurasidone
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
